November 23rd, 2023

Life Sciences BC seeks to raise the profile of our members and supporters, highlight their achievements, and promote BC's dynamic life sciences ecosystem. If you have news or a story to share, let us know.

You can find previous editions of BioLinks newsletters and other resources on our website at News/Publications.

Last week we also had the pleasure of partnering with the Consulate General of the Netherlands in Vancouver for a full-house networking event hosted by Dutch Consul General Mr. Sebastiaan Messerschmidt.

This inaugural life sciences event with the Dutch Consul on the West Coast united representatives from the Netherlands Foreign Investment Agency, the BC government, companies, investors, and sector leaders. We anticipate furthering connections between BC and the Netherlands for enhanced global health outcomes.

The LSBC team had a fantastic time in picturesque Victoria, BC, for this week's inaugural Vancouver Island Winter Social! While on the island, we met with University of Victoria President Kevin Hall, and Lisa Kalynchuk and Fraser Hof, the VP and Assistant VP of Research and Innovation, to discuss the exciting R&D initiatives at UVIC. Another highlight of our visit was a tour of Redlen Technologies, a medical device and technology company, courtesy of its COO, Jim Balcom.

The winter social event, generously hosted by Scott Phillips and his team at StarFish Medical, Canada's largest Medical Device company, was a sold-out affair that brought together the Vancouver Island sector for an evening of networking and camaraderie. Notable attendees included sector leader Alan Winter, Adjunct Professor at UVIC and Former BC Innovation Commissioner. We were privileged to have The Honourable Brenda Bailey, BC's Minister of JEDI, share remarks during the event.

As the second-largest life sciences cluster in B.C., Vancouver Island is home to 15% of the province's life sciences companies, and this vibrant community is steadily growing. We extend our gratitude to everyone who contributed to making our visit memorable and incredibly enjoyable!

We send our congratulations to PEI BioAlliance for its significant role in completing a $90 million-plus biologics expansion at BIOVECTRA's new Biomanufacturing Centre in Charlottetown. This milestone is crucial for Prince Edward Island's bioscience sector and Canada's biomanufacturing capacity, supporting domestic production for vaccines and therapeutics, strengthening the life sciences sector, and creating well-paying jobs in the region. Exciting times for PEI! Learn more. 

Member Highlights 

Acuitas Therapeutics President and CEO Thomas Madden spoke to Techcouver about the company's recent $1M BC Cancer Foundation donation for liver cancer research and the stigma surrounding the disease, resulting in limited treatment options. Read it here.

Sernova CEO Cynthia Pussinen was recently featured in a BioPharma-Reporter article on women in science. In it, she discusses her notable career journey, what drew her to the life sciences, and her advice for women interested in a scientific career. Read it here.

In a recent interview with The Associated Press, Filament Health CEO Benjamin Lightburn shared insights into Filament's choice to extract compounds like psilocybin and mescaline from natural sources such as magic mushrooms and cacti, rather than opting for synthesis. Read it here.

Nick Kadysh, CEO of PharmAla Biotech recently spoke to The Watchlist about the company's mission and its historic first shipment of MDMA and Psilocybin for patients in Australia. Watch it here.

EBD Academy invites LSBC members attending the Biotech Showcase at JMP Week to take advantage of a €200 discount for its upcoming course, Fundamentals: Due Diligence. This course provides a deeper understanding of the due diligence process for biotech partnering. You can request the discount code via email here.

New Members

Jevitty Life Science Corp is a Vancouver BC based company with the mission of developing and delivering technologies for human longevity and health-span.

TMX operates global markets and builds digital communities and analytic solutions that facilitate the funding, growth and success of businesses, traders and investors.

[Individual] Debbie Morton holds a Bachelor of Science degree in Biological Sciences from DeMontfort University and a Doctorate in Neuroscience from The University of Manchester, UK. After completing her PhD, she worked as a Postdoctoral Fellow at the National University of Singapore. Whilst in Singapore, she transitioned into the business world, working as an investor and establishing companies and investment funds. Upon relocating to Canada, Debbie focused on angel investing, with a particular interest in science, technology, and health.

Eric Atkinson has also joined the LSBC ecosystem with an Individual membership.

Welcome all to the LSBC community!

Industry Highlights

This week, Prime Minister Justin Trudeau, Minister François-Philippe Champagne and BC Premier David Eby announced a $1.05 billion investment in E-One Moli Energy, establishing a cutting-edge lithium-ion battery cell manufacturing facility and an advanced research and development centre in Maple Ridge. This initiative, supported by a BC government investment of up to $80 million and additional contributions totalling $970 million, will create 450 permanent jobs and align with BC's commitment to clean technology. Learn more.

Canada has allocated $248 million to support 34 new Canada Excellence Research Chairs (CERCs) at 18 postsecondary institutions. This funding, the largest ever awarded in a single competition, aims to attract and retain global talent across diverse research areas such as green chemistry, regenerative medicine, Indigenous leadership, climate change mitigation, and health equity. Learn more.

Canada is providing up to $3.8 million in additional funding for the Women Entrepreneurship Knowledge Hub (WEKH), a national network connecting women entrepreneurs with resources. This funding supports building a more inclusive economy, expanding partnerships, raising awareness of successes, and engaging mainstream organizations in applying knowledge and research. Learn more.

Canada has announced its support of BioTwin, an AI-based early cancer detection company, with up to $425,000 in funding through the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). This investment aligns with Canada's Biomanufacturing and Life Sciences Strategy, fostering innovation in AI for healthcare and supporting the growth of the country's life sciences ecosystem. Learn more.

PacifiCan has announced its new headquarters at Station Tower located in Surrey's economic hub, reinforcing its commitment to supporting BC businesses and fostering an inclusive economy. This strategic move enhances PacifiCan's ability to serve the Lower Mainland and contribute to the growing economies south of the Fraser Valley, aligning with the agency's expanded presence across BC. Learn more.

Dr. Ted Hewitt, Canada Research Coordinating Committee Chair & SSHRC-CRSH President, has published "The Canada Research Coordinating Committee's Journey from Vision to Action" in this month's Canadian Science Policy Centre, highlighting the organization's progress and vision for the future. Read it here.

Northway Group is investing 7 billion euros to establish BIO CITY, Europe's largest biotechnology hub, in Vilnius, Lithuania. The project includes six extensive biotech complexes spanning ten football fields. Lithuania aims for long-term economic prosperity through a science-based economy and modern technologies. Learn more.

Kudos

It has been an outstanding week for celebrating our members' many achievements! Congratulations to all mentioned below, and to those whose accomplishments are not captured here. Your successes are truly inspiring!

Roche Canada has received a nomination for the Women Leaders in Pharma - Diversity Initiative of the Year Award for enhancing diverse representation in clinical trials. See the complete list of nominees here.

Drs. Kenneth Rockwood and Oluwabukola Salami have been honoured with the Health Research Foundation (HRF) of Innovative Medicines Canada (IMC) Medal of Honour and Diversity, and Equity in Research Award, respectively. Learn more.

Dr. François Bénard of the BC Cancer Research Institute, has received the Distinguished Service Award from the Western Region Society of Nuclear Medicine (WRSNM) for outstanding contributions in PET, nuclear medicine, cancer imaging, and radioligand therapy. Learn more.

Farris Partners, Hector MacKay-Dunn, J.D., K.C., (an LSBC Board Observer) and James Hatton, K.C., have been recognized as among the Top 10 Canadian Life Sciences Corporate Lawyers set to influence 2023 by Business Today's Lawyer Awards. Find more details and the complete list of winners here.

Pfizer Canada's Najah Sampson has accepted the prestigious Prix Galien Innovative Product Award on behalf of Pfizer and BioNTech for Comirnaty, Canada's first approved COVID-19 vaccine, acknowledging its significant impact on patient care. Learn more here.

Andrea Masters and David Shum of Roche Canada received Innovative Medicines Canada’s Excellence in Leadership award. Learn more.

OBIO's President and CEO, Dr. Maura Campbell, has received the University of Ottawa’s Faculty of Medicine’s Exceptional Leadership Award at the 2023 Alumni Awards of Distinction. Learn more and see the complete list of winners here.

Drs. Poul Sorensen and Gregg Morin at BC Cancer have been awarded $500,000 USD from The Osteosarcoma Institute for their project “Harnessing the osteosarcoma surfaceome for immunotherapy targets to block metastatic capacity.” Learn more.

Congratulations to the 19 ventures that have been selected for entrepreneurship@ubc’s Venture Showcase, including LSBC members SnapCyte (a 2023 LSBC Awards “Company to Watch”), Focal Lines Technologies, and CereCura and CNANO, both participants in our current LSBC Investor Readiness Program (IRP) cohort! Learn more about this event and all the finalists here. 

People on the Move

Innovative Medicines Canada welcomes Tracey Ramsay, VP and GM at AbbVie Canada, as Vice-Chair of its Board of Directors. Learn more.

Applications Open

entrepreneurship@UBC is actively seeking applicants for its upcoming spring Venture Founder cohort, which supports UBC-affiliated entrepreneurs in advancing their ventures. The application deadline is December 1. Learn more about this program here. Register to attend an info session on Friday, November 24 here.

Aurinia Pharmaceutical is now accepting submissions for its 2024 Community Impact Grant Award, benefiting organizations serving the lupus nephritis community. Applications are due by November 30. Learn more here.

Explore the adMare Tx Accelerator program for early-stage BC-based therapeutic ventures at a Lunch & Learn event on December 7 at adMare BioInnovations' Vancouver Innovation Centre. Register here.

We invite you to explore our expanded list of current life sciences application opportunities by clicking the button below.

Upcoming LSBC events and programs at-a-glance

Nov. 29/30 - SOLD OUT - LSBC, in partnership with Biotech Primer, is pleased to present BioBasics 101: The Biology of Biotech for the Non-Scientist.

Dec. 13 - Attending J.P. Morgan Conference Week and need navigation tips? We invite you to join us for our Blakes Breakfast Speaking Series: Preparing for J.P. Morgan Week.

Dec. 14 - Join us alongside your industry colleagues for an evening of relaxed camaraderie as we toast the holiday season at the annual Life Sciences BC Holiday Party.

Jan. 16/17 - LSBC, in partnership with Biotech Primer, is pleased to present BioBasics 201: Targeted Biologics for the Non-Scientist.

We're thrilled to announce that we are one of the delivery partners for the new AccelerateIP (AIP) program, which helps startups leverage the potential of their IP.

Until next week,

Wendy and the LSBC team

The adMare Institute Examines the Critical Role of Anchor Companies in Building Globally Competitive Life Sciences Innovation Ecosystems

The adMare Institute released the findings of its first white paper, considering the critical factors required to build a thriving life sciences industry and the essential role played by anchor companies. Created in June 2023 by adMare BioInnovations, the adMare Institute focuses on addressing the current and emerging health and life science policy challenges faced by Canadians and their governments... READ MORE

ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference

ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced that the Company will be presenting at the Piper Sandler 35th Annual Healthcare Conference on Thursday, November 30, 2023, at 12:00 p.m. ET in New York. David. R. Parkinson, President, and Chief Executive Officer; Peter Virsik, Chief Operating Officer; and David S. Wood, Chief Financial Officer, will host and participate in one-on-one meetings... READ MORE

WELL Health Announces Launch of WELL AI Inbox Admin: A Revolutionary AI-Powered Solution for Clinic Inbox Management

WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (“WELL” or the “Company”), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients globally, is pleased to announce the launch of its latest AI powered product, WELL AI Inbox Admin... READ MORE

New Campaign Celebrates Canadian Rare Disease Changemakers

13 Canadian rare disease organizations, in partnership with Takeda Canada Inc. (“Takeda”,) unite to launch I Am Number 12, to raise awareness of the 1 in 12 Canadians who will be affected by a rare disease in their lifetime. The campaign highlights the challenges and needs of people living with rare diseases, and how collectively, rare diseases aren’t really that rare... READ MORE

AstraZeneca Canada Named One of Canada’s Top Employers

AstraZeneca Canada, a leading innovation-driven biopharmaceutical company, has been named one of Canada’s Top 100 Employers. The 2024 competition winners were announced by Mediacorp Canada Inc. in today’s edition of The Globe and Mail... READ MORE

Farris Partners Named Top 10 Canadian Life Sciences Leaders

Two Farris Partners, Hector MacKay-Dunn, KC and James Hatton, KC, were recently recognized as 2 of the Top 10 Canadian Life Sciences Corporate Lawyers set to influence 2023, by Business Today’s Lawyer Awards. These awards showcase the most esteemed and innovative lawyers in the Life Sciences: Corporate/Commercial realm throughout Canada, who are not just leaders in their field today but set to shape the sector in coming years... READ MORE

Canadian Research Funders Join Forces With the International Research on Research Institute

The Social Sciences and Humanities Research Council of Canada (SSHRC), the Canadian Institutes of Health Research (CIHR), and Michael Smith Health Research BC (Health Research BC) are pleased to become core partners in the Research on Research Institute (RoRI)to help ensure that Canada is at the forefront of research funding practices. As core partners, SSHRC, CIHR and Health Research BC will engage in key projects and provide input on RoRI’s strategic direction... READ MORE

AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023

AbCellera (Nasdaq: ABCL) announced that management will present at the Piper Sandler 35th Annual Healthcare Conference in New York, New York on Thursday, November 30, 2023, at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time). A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the presentation... READ MORE

InBC Announces New Investments into B.C.-based Companies

We are excited to share our recent investments into a few B.C.-based companies that are driving innovation, creating quality jobs and generating impact in the province. In addition to the potential for financial returns and benefits to British Columbia, these investments align with our impact objectives innovate for the future and elevate inclusive communities... READ MORE

Frontage Announces an Initiative to Form Global Drug Discovery Services

Frontage Laboratories has announced an initiative to form Global Drug Discovery Services within the organization. Global Drug Discovery Services will unify all operations in chemistry, biology, ADME/PK and pharmacology at various subsidiaries including Quintara Discovery and ACME Biosciences in the San Francisco Bay Area and BRI in Vancouver, Canada... READ MORE

Jemperli (Dostarlimab for Injection) Plus Carboplatin and Paclitaxel Approved in Canada as a Treatment Option for Primary Advanced or Recurrent Dmmr/Msi-H Endometrial Cancerjemperli (Dostarlimab for Injection) Plus Carboplatin and Paclitaxel Approved in Canada as a Treatment Option for Primary Advanced or Recurrent Dmmr/Msi-H Endometrial Cancer

GSK today announced that Health Canada has approved a new indication for Jemperli (dostarlimab for injection) in combination with carboplatin and paclitaxel for the treatment of adult patients with primary advanced or recurrent mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) endometrial cancer who are candidates for systemic therapy, based on Part 1 of the pivotal RUBY study... READ MORE

Innovative Medicines Canada Announces Scholarship for the University of Guelph’s One Health Program

Innovative Medicines Canada (IMC) is pleased to announce a $25,000 scholarship for the University of Guelph’s Bachelor of One Health program to mark the tenure of its outgoing board chair, Alok Kanti, the former president of Bayer Canada... READ MORE

Pender Ventures Secures $10 Million Investment From InBC to Support B2B Software and Healthtech Start-up Ecosystem

Pender Ventures is pleased to announce that InBC Investment Corp. (“InBC”) has made a $10 million investment in the Pender Technology Inflection Fund II (“PTIF II”). InBC is a Crown corporation that manages and invests a $500 million strategic investment fund created by the Province of B.C. to support high-growth businesses and venture capital funds for the benefit of British Columbians... READ MORE

PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules

PharmAla Biotech Holdings Inc., a Canadian biotechnology company dedicated to the research and development of clinical-grade LaNeo™ MDMA and novel MDXX compounds, and Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament”), a clinical-stage natural psychedelic drug development company, announced the GMP release of a second batch of MDMA capsules encapsulated at Filament’s Metro Vancouver facility... READ MORE

StarFish Medical joins Festival of Trees to support BC Children’s Hospital and Oncology Research

StarFish Medical, one of North America’s largest medical device design companies, joins Festival of Trees at the Bay Centre in Victoria, BC – an annual event hosted by the BC Children’s Hospital Foundation to raise funds and support oncology research at BC Children’s Hospital in Vancouver... READ MORE

Canadian Medical Isotope Ecosystem Announces Development Fund to Foster Innovation in the Canadian Isotope Industry

The Canadian Medical Isotope Ecosystem Development Fund (CMIEDF) will invest in Canadian projects that advance medical isotope supply or develop emerging technologies in radiotherapeutics and diagnostics. On November 16, the Canadian Medical Isotope Ecosystem (CMIE) – an initiative co-led by TRIUMF Innovations and the Centre for Probe Development and Commercialization (CPDC) – held an industry information session to announce the launch of the Canadian Medical Isotope Ecosystem Development Fund (CMIEDF)... READ MORE

Health Research Foundation Announces the Recipients of Two Health Research Awards

The Health Research Foundation (HRF) of Innovative Medicines Canada (IMC) is pleased to announce that Dr. Kenneth Rockwood has been named the 2023 recipient of its Medal of Honour, and that Dr. Oluwabukola Salami is the first recipient of its new Diversity and Equity in Research Award... READ MORE

Kootenay Boundary Regional Hospital Expansion Complete

The new pharmacy has tripled in size featuring a new patient education room for private consultations and better ventilation spaces making it safer for staff and patients. The new ambulatory care wing was built above the expanded emergency department. Ambulatory care includes procedures for outpatients, such as endoscopies and cystoscopies, and other minor surgical procedures...READ MORE

Pfizer and BioNTech Receive Prestigious Prix Galien Canada Innovative Product Award for COMIRNATY, Canada’s First Approved COVID-19 Vaccine

Pfizer Canada ULC and BioNTech SE announced that COMIRNATY, the Pfizer-BioNTech COVID-19 Vaccine, has been named the 2023 winner of the Prix Galien Canada Innovative Product Award. COMIRNATY is indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals 6 months of age and older... READ MORE

Getinge’s First Connected OR Table is Here

The launch of Maquet Corin brings Getinge a step forward in two important areas. In addition to being the company´s first connected OR table, it also pioneers a modular approach with the same technical components used across different OR tables... READ MORE

Finch Media is a public relations, strategic communications and health communications agency that supports clients in a wide variety of sectors, including automotive, education, entertainment, biotech, life sciences, and consumer packaged goods (CPG). We help our clients identify, develop, and deploy their most compelling stories to make real connections, drive results, and have a lasting impact. Our expert team is based in Vancouver, and our work has benefitted numerous clients throughout Canada, the United States, and Europe.

As an award-winning agency, Finch Media is driven by client success. We pride ourselves on delivering value and the highest quality of services as we consistently strive to exceed client expectations. Get in touch with us today to see how we can help you spread the word and create meaning across all of your communications. Let us help you soar to new heights. LEARN MORE

BIOVECTRA Launches Specialized Capabilities in Mrna Drug Product Development and Biomanufacturing

“Today’s grand opening of BIOVECTRA’s new state-of-the-art facility strengthens Atlantic Canada’s status as a hub for biomanufacturing and life sciences. Our Government’s participation to this project is another important step towards cementing Canada’s position as a global leader in the sector. It enables BIOVECTRA to boost Canada’s domestic production capacity for vaccines and therapeutics for Canadians, while building a strong life and science sector and creating hundreds of well-paying jobs in the region.” -The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry... READ MORE

Government of Canada Announces Location of New PacifiCan Headquarters in Surrey

The Honourable Harjit S. Sajjan, Minister of Emergency Preparedness and Minister responsible for the Pacific Economic Development Agency of Canada (PacifiCan), announced PacifiCan’s new home at Station Tower near City Centre, Surrey’s growing economic hub. The announcement was made at the nearby SFU Surrey campus during the launch of Circle Innovation’s Healthtech SME Program – a PacifiCan-funded project... READ MORE

Government of Canada Invests in BioTwin to Fund Innovative Artificial Intelligence Technology

Canadian small and medium-sized businesses play a vital role in driving innovation and contributing to Canada’s vibrant research and development ecosystem. As more and more companies harness the power of artificial intelligence, the Government of Canada is delivering on its commitment to support the growth of Canadian businesses while helping to position Canada as a world leader in responsible artificial intelligence research and innovation... READ MORE

Minister Valdez Announces Nearly $4 Million to Continue Supporting Women Entrepreneurs Across Canada

The Honourable Rechie Valdez, Minister of Small Business, joined by the Honourable Marci Ien, Minister for Women and Gender Equality and Youth, announced additional funding of up to $3.8 million for the Women Entrepreneurship Knowledge Hub (WEKH) to continue providing support for women entrepreneurs across the country... READ MORE

Government of Canada Welcomes World-Renowned Researchers That Will Push the Boundaries of Innovation

The Honourable Terry Beech, Minister of Citizens’ Services, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced $248 million in support of 34 new Canada Excellence Research Chairs (CERCs) at 18 Canadian postsecondary institutions. This investment includes funding for new research chairs, as announced in Budget 2022. It represents the largest number of CERCs awarded in a single competition in the history of the program. The funding will allow the new Chairs to establish research facilities in Canada and contribute to their institutions’ pursuit of excellence in research, train young scholars and scientists, and develop a new generation of world-class talent... READ MORE

The Largest Biotech City in Europe Will Soon Be Built, With an Investment Amounting to 7 Billion Euros

Northway Group is embarking on a project to establish Europe’s largest biotechnology hub, BIO CITY, in Vilnius, the capital of Lithuania. It includes 6 large biotechnological complexes – 4 state-of-the-art GMP manufacturing plants and 2 advanced scientific research centres – that will be built in an area equivalent to 10 football fields. The total investment for this biotech campus is projected to reach approximately 7 billion euros over the next decade... READ MORE

Hundreds of Clean, Highly Skilled Jobs Coming to Maple Ridge

A $1.05-billion partnership between E-One Moli and the governments of B.C. and Canada will bring lithium-ion battery cell production to Maple Ridge and create 450 high-quality, permanent jobs that are key to growing the province’s clean economy. The Government of B.C. is contributing as much as $80 million to E-One Moli’s new facility in Maple Ridge, which will anchor the company’s North American production. The production facility will be Western Canada’s first high-performance lithium-ion battery cell manufacturing facility, creating a new hub in the global battery component supply chain... READ MORE

Senior/Principal Scientist, Preclinical Pharmacology

At Abdera Therapeutics, we are looking for curious and committed individuals who are ready for the opportunity to transform the way people living with cancer can be treated. We are devoted to advancing novel treatment options that offer new hope to families facing devastating diagnoses. We are in search of team members who work collaboratively with a diverse group of colleagues, respectfully engaging one another while collectively and inclusively tackling any challenges we may face. We are building an exciting and fast paced company passionate about discovering and developing tomorrow’s most innovative cancer therapies...LEARN MORE

Research Associate

Reporting to the Manager, and under the guidance of a research supervisor, the Research Associate designs the experimental approaches for various stages of an applied research project, directs research assistants and/or students, and communicates the results to the research supervisor, thus contributing to the success of research programs and/or projects. The focus of the position is applied research work related to molecular biology and genetics, including use of typical sequencing protocols and instruments (for PCR, qPCR, SNP- and SSR-based genotyping), and related bioinformatic methods. This may include working with single or multiple stakeholders, single or several project deliverables, and the use of instrumentation...LEARN MORE

Senior Director Medical Affairs

The Director, Medical Affairs will be responsible for defining and implementing KOL strategies to develop and maintain positive KOL endorsement and product champions for Eupraxia in OA diseases. The role will also be responsible for leading Eupraxia medical education initiatives and conference activities...LEARN MORE

Quality Control Supervisor – Deeley Research Centre, Victoria

The Quality Control Supervisor will support the manufacturing, quality control and quality assurance activities for the BCCA’s Cancer Immunotherapy Program, at the BCCA's Deeley Research Centre (DRC). The Quality Control Supervisor will provide supervision of the Quality Control group, ensuring efficient, orderly and seamless operation of the quality control laboratory at the CFIL including resource scheduling...LEARN MORE

Research Associate II, Protein Engineering

The role involves active participation in protein purification for multispecific antibodies to support research. Responsibilities include characterizing protein therapeutics, designing and executing experiments for screening antibody-based therapeutics, troubleshooting methods, and analyzing data. The candidate must maintain an organized lab, adhere to scientific standards and OH&S regulations, and actively foster collaborative relationships within the organization...LEARN MORE

Research Associate II – Protein Sciences

As a Research Associate II in Protein Sciences within the Integrated Sciences group, your key responsibilities include supporting protein activities, assisting the antibody generation team, documenting results, collaborating across teams, and managing program timelines to advance therapeutic efforts. Join our motivated drug discovery team, dedicated to delivering transformative medicines to patients while fostering an innovative and collaborative environment...LEARN MORE

Research Associate II – Antibody Generation

As a Research Associate II in the Antibody Generation group, you'll be responsible for optimizing antibody generation platforms, identifying lead antibody candidates, collaborating across teams, documenting results, presenting data, supporting innovative research strategies, and fostering a culture of innovation and collaboration. Join our dedicated drug discovery team with a focus on delivering transformative medicines to patients...LEARN MORE

Associate Scientist – Molecular Biology, Integrated Sciences

As an Associate Scientist in the Integrated Sciences group, your key responsibilities involve developing innovative assay solutions, providing support to the antibody generation team, improving core platforms, documenting results, collaborating across functions, managing program timelines, and fostering innovation. We seek candidates passionate about innovation and technical challenges to join our motivated drug discovery team dedicated to delivering transformative medicines while maintaining a culture of respect and trust...LEARN MORE

Senior Scientist, Formulation

NanoVation Therapeutics (NTx) is looking for an innovative and collaborative Senior Scientist, Formulation to join our team. Reporting to the CSO, the Senior Scientist, Formulation will work closely with the Formulation Team and will be responsible for designing and executing protocols related to internal and client-based projects, and subsequent data analysis. Our ideal candidate thrives on contributing collaboratively in a fast-paced, innovative environment and is open and interested in learning a variety of different research techniques...LEARN MORE

Scientist, Preclinical Development

This is a full-time Scientist role on the Preclinical Development team at Integrated Nanotherapeutics Inc. involving work across multiple sites: headquarters in Burnaby, BC, with in vivo research activities and flow cytometry conducted at sites in Vancouver, BC and flexibility for some remote work. The successful candidate will contribute to our R&D programs in antigen-specific immune tolerance by applying in vivo mouse and cellular immunology skills to develop and advance lead lipid nanoparticle-based products through preclinical pipelines...LEARN MORE

Biomanufacturing Trainer and Site Manager

Reporting to the Associate Director of Technical Training they will take a leadership role in overseeing the set-up and operations of the greater Vancouver Training Facility and supporting the company’s overall strategy. As an expert in the field of biopharmaceutical manufacturing and bioprocessing, the Biomanufacturing Trainer/Site Lead will work with the Associate Director of Technical Training and other company team members to deliver world-class in-person, virtual and practical hands-on training to a variety of learners...LEARN MORE

Associate I

The QC Associate is responsible for performing routine samples analysis in accordance with GMP and Evonik policies and practices. The QC Associate will also assist with equipment calibration/qualification and analytical method validation, as well as participating in quality system improvement initiatives. This is a lab-based position which will entail a high volume of testing in a regulated laboratory environment...LEARN MORE

Jevitty Life Science Corp is a Vancouver BC based company, with the mission of developing and delivering technologies for human longevity and healthspan.

The Bodycomp division of Jevitty (www.bodycomp.ca) provides dexa body composition scans at multiple locations in the Lower Mainland, as well as NeuroCatch brain health diagnostic scans.

Jevitty invests in and participates with various companies that are working on leading edge projects to further the objectives of living healthy and happy well beyond the current age expectancy.

Jevitty also has an interactive app that provides users with a useful dashboard for ongoing healthy activities, products and services, on both the IOS and Android platforms. LEARN MORE

Stay current by subscribing to this and our events newsletter!

Follow LSBC on Social Media!